The moral corporation /:
Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge ; New York :
Cambridge University Press,
2006.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded. |
| Beschreibung: | 1 online resource (1 volume) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 0511169310 9780511169311 0511168888 9780511168888 9780511616860 0511616864 9786610436996 6610436991 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm69198740 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 060523s2006 enk ob 001 0deng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCQ |d TUU |d OCLCQ |d OCLCF |d OCLCO |d OCLCQ |d UAB |d BAKER |d IDEBK |d AUW |d OL$ |d OCLCQ |d DHA |d OCLCQ |d HTC |d OCLCQ |d OCLCO |d N$T |d WY@ |d MNS |d OCLCA |d OCLCQ |d K6U |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 019 | |a 94942622 |a 144521749 |a 756843675 |a 814393855 |a 819634392 |a 824548454 |a 857277086 |a 912899992 | ||
| 020 | |a 0511169310 |q (electronic bk.) | ||
| 020 | |a 9780511169311 |q (electronic bk.) | ||
| 020 | |a 0511168888 |q (electronic bk.) | ||
| 020 | |a 9780511168888 |q (electronic bk.) | ||
| 020 | |a 9780511616860 |q (electronic bk.) | ||
| 020 | |a 0511616864 |q (electronic bk.) | ||
| 020 | |a 9786610436996 |q (electronic bk.) | ||
| 020 | |a 6610436991 |q (electronic bk.) | ||
| 020 | |z 0521683831 |q (pbk.) | ||
| 020 | |z 9780521683838 |q (pbk.) | ||
| 020 | |z 0521864550 |q (cloth) | ||
| 020 | |z 9780521864558 |q (cloth) | ||
| 020 | |z 1280436999 | ||
| 020 | |z 9781280436994 | ||
| 035 | |a (OCoLC)69198740 |z (OCoLC)94942622 |z (OCoLC)144521749 |z (OCoLC)756843675 |z (OCoLC)814393855 |z (OCoLC)819634392 |z (OCoLC)824548454 |z (OCoLC)857277086 |z (OCoLC)912899992 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a HD9666.9.M4 |b V34 2006eb | |
| 072 | 7 | |a BUS |x 032000 |2 bisacsh | |
| 072 | 7 | |a BUS |x 077000 |2 bisacsh | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 082 | 7 | |a 338.7/616151092 |a B |2 22 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Vagelos, P. Roy. | |
| 245 | 1 | 4 | |a The moral corporation / |c P. Roy Vagelos, Louis Galambos. |
| 260 | |a Cambridge ; |a New York : |b Cambridge University Press, |c 2006. | ||
| 300 | |a 1 online resource (1 volume) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded. | ||
| 610 | 2 | 0 | |a Merck & Co. |x Management. |
| 600 | 1 | 0 | |a Vagelos, P. Roy. |
| 600 | 1 | 7 | |a Vagelos, P. Roy |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJfxd9hqwVPKkv7bMVMHG3 |
| 610 | 2 | 7 | |a Merck & Co. |2 fast |
| 650 | 0 | |a Pharmaceutical industry |x Moral and ethical aspects |z United States. | |
| 650 | 0 | |a Business ethics. |0 http://id.loc.gov/authorities/subjects/sh85018297 | |
| 650 | 0 | |a Social responsibility of business. |0 http://id.loc.gov/authorities/subjects/sh90005735 | |
| 650 | 6 | |a Industrie pharmaceutique |x Aspect moral |z États-Unis. | |
| 650 | 6 | |a Morale des affaires. | |
| 650 | 6 | |a Entreprises |x Responsabilité sociale. | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Infrastructure. |2 bisacsh | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Corporate & Business History. |2 bisacsh | |
| 650 | 7 | |a Business ethics |2 fast | |
| 650 | 7 | |a Management |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |x Moral and ethical aspects |2 fast | |
| 650 | 7 | |a Social responsibility of business |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Galambos, Louis. | |
| 776 | 0 | 8 | |i Print version: |a Vagelos, P. Roy. |t Moral corporation. |d Cambridge ; New York : Cambridge University Press, 2006 |z 0521864550 |z 0521683831 |w (DLC) 2006002543 |w (OCoLC)63179037 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=156569 |3 Volltext |
| 938 | |a Baker & Taylor |b BKTY |c 60.00 |d 60.00 |i 0521864550 |n 0006672443 |s active | ||
| 938 | |a EBSCOhost |b EBSC |n 156569 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 43699 | ||
| 938 | |a YBP Library Services |b YANK |n 2431574 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm69198740 |
|---|---|
| _version_ | 1816881636550115328 |
| adam_text | |
| any_adam_object | |
| author | Vagelos, P. Roy |
| author2 | Galambos, Louis |
| author2_role | |
| author2_variant | l g lg |
| author_facet | Vagelos, P. Roy Galambos, Louis |
| author_role | |
| author_sort | Vagelos, P. Roy |
| author_variant | p r v pr prv |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.9.M4 V34 2006eb |
| callnumber-search | HD9666.9.M4 V34 2006eb |
| callnumber-sort | HD 49666.9 M4 V34 42006EB |
| callnumber-subject | HD - Industries, Land Use, Labor |
| collection | ZDB-4-EBA |
| contents | The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards. |
| ctrlnum | (OCoLC)69198740 |
| dewey-full | 338.7/616151092 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.7/616151092 B |
| dewey-search | 338.7/616151092 B |
| dewey-sort | 3338.7 9616151092 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04755cam a2200817 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm69198740 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">060523s2006 enk ob 001 0deng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TUU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UAB</subfield><subfield code="d">BAKER</subfield><subfield code="d">IDEBK</subfield><subfield code="d">AUW</subfield><subfield code="d">OL$</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DHA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">HTC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">WY@</subfield><subfield code="d">MNS</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">94942622</subfield><subfield code="a">144521749</subfield><subfield code="a">756843675</subfield><subfield code="a">814393855</subfield><subfield code="a">819634392</subfield><subfield code="a">824548454</subfield><subfield code="a">857277086</subfield><subfield code="a">912899992</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0511169310</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511169311</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0511168888</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511168888</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511616860</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0511616864</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786610436996</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6610436991</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0521683831</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780521683838</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0521864550</subfield><subfield code="q">(cloth)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780521864558</subfield><subfield code="q">(cloth)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1280436999</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781280436994</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)69198740</subfield><subfield code="z">(OCoLC)94942622</subfield><subfield code="z">(OCoLC)144521749</subfield><subfield code="z">(OCoLC)756843675</subfield><subfield code="z">(OCoLC)814393855</subfield><subfield code="z">(OCoLC)819634392</subfield><subfield code="z">(OCoLC)824548454</subfield><subfield code="z">(OCoLC)857277086</subfield><subfield code="z">(OCoLC)912899992</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD9666.9.M4</subfield><subfield code="b">V34 2006eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS</subfield><subfield code="x">032000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS</subfield><subfield code="x">077000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">KNDP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">338.7/616151092</subfield><subfield code="a">B</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vagelos, P. Roy.</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The moral corporation /</subfield><subfield code="c">P. Roy Vagelos, Louis Galambos.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Cambridge ;</subfield><subfield code="a">New York :</subfield><subfield code="b">Cambridge University Press,</subfield><subfield code="c">2006.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 volume)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.</subfield></datafield><datafield tag="610" ind1="2" ind2="0"><subfield code="a">Merck & Co.</subfield><subfield code="x">Management.</subfield></datafield><datafield tag="600" ind1="1" ind2="0"><subfield code="a">Vagelos, P. Roy.</subfield></datafield><datafield tag="600" ind1="1" ind2="7"><subfield code="a">Vagelos, P. Roy</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJfxd9hqwVPKkv7bMVMHG3</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Merck & Co.</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Business ethics.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85018297</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Social responsibility of business.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh90005735</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Industrie pharmaceutique</subfield><subfield code="x">Aspect moral</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Morale des affaires.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Entreprises</subfield><subfield code="x">Responsabilité sociale.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS</subfield><subfield code="x">Infrastructure.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS</subfield><subfield code="x">Corporate & Business History.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Business ethics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Management</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social responsibility of business</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galambos, Louis.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Vagelos, P. Roy.</subfield><subfield code="t">Moral corporation.</subfield><subfield code="d">Cambridge ; New York : Cambridge University Press, 2006</subfield><subfield code="z">0521864550</subfield><subfield code="z">0521683831</subfield><subfield code="w">(DLC) 2006002543</subfield><subfield code="w">(OCoLC)63179037</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=156569</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Baker & Taylor</subfield><subfield code="b">BKTY</subfield><subfield code="c">60.00</subfield><subfield code="d">60.00</subfield><subfield code="i">0521864550</subfield><subfield code="n">0006672443</subfield><subfield code="s">active</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">156569</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">43699</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2431574</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocm69198740 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:15:52Z |
| institution | BVB |
| isbn | 0511169310 9780511169311 0511168888 9780511168888 9780511616860 0511616864 9786610436996 6610436991 |
| language | English |
| oclc_num | 69198740 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (1 volume) |
| psigel | ZDB-4-EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Cambridge University Press, |
| record_format | marc |
| spelling | Vagelos, P. Roy. The moral corporation / P. Roy Vagelos, Louis Galambos. Cambridge ; New York : Cambridge University Press, 2006. 1 online resource (1 volume) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards. Print version record. Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded. Merck & Co. Management. Vagelos, P. Roy fast https://id.oclc.org/worldcat/entity/E39PBJfxd9hqwVPKkv7bMVMHG3 Merck & Co. fast Pharmaceutical industry Moral and ethical aspects United States. Business ethics. http://id.loc.gov/authorities/subjects/sh85018297 Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Industrie pharmaceutique Aspect moral États-Unis. Morale des affaires. Entreprises Responsabilité sociale. BUSINESS & ECONOMICS Infrastructure. bisacsh BUSINESS & ECONOMICS Corporate & Business History. bisacsh Business ethics fast Management fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Galambos, Louis. Print version: Vagelos, P. Roy. Moral corporation. Cambridge ; New York : Cambridge University Press, 2006 0521864550 0521683831 (DLC) 2006002543 (OCoLC)63179037 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=156569 Volltext |
| spellingShingle | Vagelos, P. Roy The moral corporation / The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards. Merck & Co. Management. Vagelos, P. Roy. Vagelos, P. Roy fast https://id.oclc.org/worldcat/entity/E39PBJfxd9hqwVPKkv7bMVMHG3 Merck & Co. fast Pharmaceutical industry Moral and ethical aspects United States. Business ethics. http://id.loc.gov/authorities/subjects/sh85018297 Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Industrie pharmaceutique Aspect moral États-Unis. Morale des affaires. Entreprises Responsabilité sociale. BUSINESS & ECONOMICS Infrastructure. bisacsh BUSINESS & ECONOMICS Corporate & Business History. bisacsh Business ethics fast Management fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85018297 http://id.loc.gov/authorities/subjects/sh90005735 |
| title | The moral corporation / |
| title_auth | The moral corporation / |
| title_exact_search | The moral corporation / |
| title_full | The moral corporation / P. Roy Vagelos, Louis Galambos. |
| title_fullStr | The moral corporation / P. Roy Vagelos, Louis Galambos. |
| title_full_unstemmed | The moral corporation / P. Roy Vagelos, Louis Galambos. |
| title_short | The moral corporation / |
| title_sort | moral corporation |
| topic | Merck & Co. Management. Vagelos, P. Roy. Vagelos, P. Roy fast https://id.oclc.org/worldcat/entity/E39PBJfxd9hqwVPKkv7bMVMHG3 Merck & Co. fast Pharmaceutical industry Moral and ethical aspects United States. Business ethics. http://id.loc.gov/authorities/subjects/sh85018297 Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Industrie pharmaceutique Aspect moral États-Unis. Morale des affaires. Entreprises Responsabilité sociale. BUSINESS & ECONOMICS Infrastructure. bisacsh BUSINESS & ECONOMICS Corporate & Business History. bisacsh Business ethics fast Management fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast |
| topic_facet | Merck & Co. Management. Vagelos, P. Roy. Vagelos, P. Roy Merck & Co. Pharmaceutical industry Moral and ethical aspects United States. Business ethics. Social responsibility of business. Industrie pharmaceutique Aspect moral États-Unis. Morale des affaires. Entreprises Responsabilité sociale. BUSINESS & ECONOMICS Infrastructure. BUSINESS & ECONOMICS Corporate & Business History. Business ethics Management Pharmaceutical industry Moral and ethical aspects Social responsibility of business United States |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=156569 |
| work_keys_str_mv | AT vagelosproy themoralcorporation AT galamboslouis themoralcorporation AT vagelosproy moralcorporation AT galamboslouis moralcorporation |